Sreekumari Pushpoth

Learn More
AIM To analyse the benefit of intravitreal ranibizumab over 4 years for patients with neovascular age-related macular degeneration (AMD). METHODS A retrospective case note review of all patients who started treatment between August 2007 and September 2009 in our unit, minimum follow-up 2 years, maximum 4 years. The main outcome measures were: numbers of(More)
PURPOSE The aim of the study was to precisely quantify the relationship between the central corneal points, namely the pupillary centre and the thinnest point in the central cornea, in terms of their thickness and location in healthy adults. METHODS 120 eyes of 60 healthy adult volunteers underwent pachymetry with a Scheimpflug imaging system (Pentacam).(More)
  • 1